diltiazem has been researched along with sr 33557 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatelain, P; Clinet, M; Gubin, J; Lucchetti, J; Mahaux, J; Nisato, D; Polster, P; Rosseels, G | 1 |
| Clinet, M; de Vogelaer, H; Gubin, J; Houben, C; Inion, H; Lucchetti, J; Mahaux, J; Peiren, M; Polster, P; Rosseels, G | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Beaufort, P; Chatelain, P; Clinet, M; Laruel, R; Meysmans, L; Nokin, P | 1 |
| Chatelain, P; Christophe, B; Clinet, M; Manning, AS; Polster, P | 1 |
5 other study(ies) available for diltiazem and sr 33557
| Article | Year |
|---|---|
A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
Topics: Animals; Binding Sites; Brain; Calcium Channel Blockers; Guinea Pigs; Indolizines; Male; Phenethylamines; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1992 |
Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
Topics: Animals; Calcium Channel Blockers; Cerebral Cortex; Guinea Pigs; Heterocyclic Compounds; Indolizines; Male; Muscle, Smooth, Vascular; Phenethylamines; Rats; Rats, Wistar; Structure-Activity Relationship | 1993 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Topics: Animals; Binding Sites; Calcium; Calcium Channel Blockers; Diltiazem; In Vitro Techniques; Indolizines; Isradipine; Male; Myocardium; Oxadiazoles; Phenethylamines; Radioligand Assay; Rats; Rats, Inbred Strains; Sarcolemma; Verapamil | 1990 |
In vitro characterization of a novel Ca2+ entry blocker: SR 33805.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Diltiazem; Heart Rate; In Vitro Techniques; Indoles; Indolizines; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Phenethylamines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Sarcolemma; Sulfones; Verapamil | 1993 |